Evaluation of [11C]RTI-121 as a selective radioligand for PET studies of the dopamine transporter

Nuclear Medicine and Biology

Volumn 23, Issue 3, 1996, Pages 377-384

  Hume, Susan P ^a   Luthra, Sajinder K ^a   Brown, David J ^a   Opacka Juffry, Jolanta ^a   Osman, Safiye ^a   Ashworth, Sharon ^a   Myers, Ralph ^a   Brady, Frank ^a   Carroll, F Ivy ^b   Kuhar, Michael J ^c   Brooks, David J ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b RTI INTERNATIONAL   (United States)

^c NIDA Addiction Research Center   (United States)

Author keywords

Dopamine transporter; Positron emission tomography; RTI 121

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID ISOPROPYL ESTER; CARBON 11; CITALOPRAM; VANOXERINE; CARBON; CARRIER PROTEIN; COCAINE; DIAGNOSTIC AGENT; DOPAMINE; DOPAMINE TRANSPORTER; DRUG DERIVATIVE; MEMBRANE PROTEIN; NERVE PROTEIN; PLASMA PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY; RAT; ANIMAL; BIOTRANSFORMATION; BRAIN; CEREBELLUM; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CORPUS STRIATUM; MALE; METABOLISM; METHODOLOGY; RADIOASSAY; SCINTISCANNING; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ANIMALS; BIOTRANSFORMATION; BLOOD PROTEINS; BRAIN; CARBON RADIOISOTOPES; CARRIER PROTEINS; CEREBELLUM; COCAINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0029665316     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/0969-8051(96)00019-4     Document Type: Article

References (44)

1. Aquilonius S.-M., Bergström K., Eckernäs S. A., Hartvig P., Leenders K. L., Lundquist H., Antoni G., Gee A., Rimland A., Uhlin J. and Langström B. (1987) In vivo evaluation of striatal dopamine reuptake sites using 11C-nomifensine and poisitron emission tomography. Acta Neurol. Scand. 76, 283-287.
2. Bloomfield P. M., Rajeswaran S., Spinks T. J., Hume S. P., Myers R., Ashworth S., Clifford K. M., Jones W. F., Byars L. G., Young J., Andreaco M., Williams C. W., Lammertsma A. A. and Jones T. (1995) Design and physical characteristics of a small animal positron emission tomograph. Phys. Med. Biol 40, 1105-1126.
3. Boja J. W., Cline E. J., Carroll F. I., Lewin A. H., Philip A., Dannals R., Wong D., Scheffel U. and Kuhar M. J. (1992a) High potency cocaine analogs: Neurochemical imaging, and behavioral studies. Ann. N.Y. Acad. Sci. 654, 282-291.
4. Boja, J. W., McNeill R. M., Lewin A. H., Abraham P., Carroll F. I. and Kuhar M.J. (1992b) Selective dopamine transporter inhibition by cocaine analogs. Neuroreport 3, 984-986.
5. Boja J. W., Kuhar M. J., Kopajtic T., Yang E., Abraham P., Lewin A. H. and Carroll F. I. (1994) Secondary amine analogues of 3β-(4'-substituted phenyl)tropane-2β-carboxylic acid esters and N-norcocaine exhibit enhanced affinity for serotonin and norepinephrine transporters. J. Med. Chem. 37, 1220-1223.
6. 125I]iodophenyl)tropane-2β-carboxylic acid isopropyl ester. Mol. Pharmacol. 47, 779-786.
7. 11C]RTI-121 - A potential radioligand for PET studies of the dopamine transporter. J. Labelled Cmpds. Radiopharm. 35, 483-484.
8. 123I]β-CIT: Binding kinetics in the human brain. J. Neural. Transm. Gen. Sect. 94, 137-146.
9. Carroll F. I., Gao Y., Abraham P., Lewin A. H., Lew R., Patel A., Boja J. W. and Kuhar M. J. (1992) Probes for the cocaine receptor: Potentially irreversible ligands for the dopamine transporter. J. Med. Chem. 35, 1813-1817.
10. Carroll F. I., Kotian P., Dehghani A., Gray J. L., Kuzemko M. A., Parham K. A., Abraham P., Lewin A. H., Boja J. W. and Kuhar M. J. (1995) Cocaine and 3-β-(4′ substituted phenyl)tropane-2β-carboxylic acid ester and amide analogues: New high-affinity and selective compounds for the dopamine transporter. J. Med. Chem. 38, 379-388.
11. 123I]RTI-55 to dopamine transporters: Pharmacology and regional distribution with autoradiography. Synapse 12, 37-46,
12. 11C]dl-threo-methylphenidate for the presynaptic dopaminergic neuron. Synapse 18, 152-160.
13. 11C]β-CIT binding to monoamine transporters in the monkey and human brain. Synapse 16, 93-103.
14. Foulon G., Garreau L., Chalon S., Desplanches G., Frangin Y., Besnard J.-C., Baulieu J. L. and Guilloteau D. (1992) Synthesis and in vitro binding properties of halogenated analogues of GBR as new dopamine uptake carrier ligands. Nucl. Med. Biol. 19, 597-600.
15. 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann. Neurol. 34, 423-431.
16. Halldin C., Farde L., Karlsson P., Müller L., Hall H., Högberg T., Neumeyer J. L. and Swahn C.-G. (1993) Radioligands for PET examination of the preand postsynaptic dopaminergic neurons. J. Cereb. Blood Flow Metab. 13, S299.
17. 11C]-CFT and PET in a primate model of parkinsonism. Neuroreport 3, 265-268.
18. Hyttel J. (1982) Citalopram - pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog. Neuropsychopharmacol. Biol. Psychiatry 6, 277-295.
19. Innis R. B. (1994) Single-photon emission tomography imaging of dopamine terminal innervation: A potential clinical tool in Parkinson's disease. Eur. J. Nucl. Med. 21, 1-5,
20. 125I]RTI-55. Synapse 12, 99-111.
21. Kelley A. E. and Lang C. G. (1989) Effects of GBR 12909, a selective dopamine uptake inhibitor, on motor activity and operant behaviour in the rat. Eur. J. Pharmacol. 167, 385-395.
22. 18F]GBR 13119: Imaging the dopamine uptake system in vivo. Nucl. Med. Biol. 16, 569-576.
23. Kim S. E., Scheffel U., Boja J. W. and Kuhar M. J. (1994) Effect of reserpine upon binding of H-3 WIN-35,428 to dopamine uptake sites. J. Nucl. Med. 35, 199P.
24. Kuikka J. T., Bergström K. A., Vanninen E., Laulaumaa V., Hartikainen P. and Lansimies E. (1993) Initial experience with single-photon emission tomography using iodine-123-labelled 2β-carbomethoxy-3β-(4-iodophenyl)-tropane. Eur. J. Nucl. Med. 20, 783-786.
25. Laihinen A. O., Rinne J. O., NÅgren K. Å., Lehikoinen P. K., Oikonen V. J., Ruotsalainen U. H., Ruottinen H. M. and Rinne U. K. (1995) PET studies on brain monoamine transporters with carbon-11-β-CIT in Parkinson's disease. J. Nucl. Med, 36, 1263-1267.
26. 123I]β-CIT binding to dopamine transporters in healthy human subjects. J. Cereb. Blood Flow Metab. 14, 982-994.
27. 11C]Schering 23390. J. Labelled Cmpds. Radiopharm. 32, 518-520.
28. 11C]buprenorphine from 3-O-trityl protected precursors. Appl. Radiat. Isot. 45, 857-873.
29. 3H]2β-carbomethoxy-3β-(4-fluorophenyl)tropane. Mol. Pharmacol. 36, 518-524.
30. McElvain J. S. and Schenk J. O. (1992) A multisubstrate mechanism of striatal dopamine uptake and its inhibition by cocaine. Biochem. Pharmacol. 43, 2189-2199.
31. 11C]β-CIT, a cocaine analogue: Preparation, autoradiography and preliminary PET investigations, Nucl. Med. Biol. 20, 249-255.
32. Müller L., Halldin C., Foged C., Karlsson P., Hall H., Swahn C.-G., Suzdak P. D., Hohlweg R., Nielsen E. B. and Farde L. (1994) Preparation of a potential positron emission tomographic radioligand for the dopamine transporter. Eur. J. Nucl. Med. 21, 131-137.
33. 123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane: High-affinity SPECT radiotracer of monoamine reuptake sites in brain. J. Med. Chem. 34, 3144-3146.
34. Perese D. A., Ulman J., Viola J., Ewing S. E. and Bankiewicz K. S. (1989) A 6-hydroxydopamme-induced selective parkinsonian rat model. Brain Res. 494, 285-293.
35. Reith M. E. A., de Costa B., Rice K. C. and Jacobson A. E. (1992) Evidence for mutually exclusive binding of cocaine, BTCP, GBR 12935, and dopamine to the dopamine transporter. Eur. J. Pharmacol. Mol. Pharmacol. 227, 417-425.
36. Robb R. A. and Hanson D. P. (1991) A software system for interactive and quantitative visualization of multidimensional biomedical images. Australas. Phys. Eng. Sci. Med. 14, 9-30.
37. 3H]carboxymethoxy-3β-(4-fluorophenyl)tropane to the serotonin trans-porter. Mol. Pharmacol. 40, 421-426.
38. 11C]nomifensine uptake using positron emission tomography. J. Cereb. Blood Flow Metab. 10, 307-316.
39. 123I]IPCIT as single-photon emission tomography radiotracers for the dopamine transporter in nonhuman primates. Eur. J. Nucl. Med. 22, 4-11.
40. Shaya E. K., Scheffel U., Dannals R. F., Ricaurte G. A., Carroll F. I., Wagner Jr. N. N., Kuhar M. J. and Wong D. F. (1992) In vivo imaging of dopamine reuptake sites in the primate brain using single photon emission computed tomography (SPECT) and iodine-123 labelled RTI-55. Synapse 10, 169-172.
41. Scheffel U., Dannals R. F., Wong D. F., Yokoi F., Carroll F. I. and Kuhar M. J. (1992) Dopamine transporter imaging with novel, selective cocaine analogs. Neuroreport 3, 969-972.
42. Volkow N. D., Fowler J. S., Wolf A. P., Wang G.-J., Logan J., MacGregor R., Dewey S. L., Schlyer D. and Hitzemann R. (1992) Distribution and kinetics of carbon-11-cocaine in the human body measured with PET. J. Nucl. Med. 33, 521-525.
43. Volkow N. D., Fowler J. S., Logan J., Gatley S. J., Dewey S. L., MacGregor R. R., Schlyer D. J., Pappas N., King P., Wang G.-J. and Wolf A. P. (1995) Carbon-11-cocaine binding compared at subpharmacological and pharmacological doses: A PET study. J. Nucl. Med. 36, 1289-1297.
44. Wong D. F., Shaya E. K., Yung B., Scheffel U., Dannals R. F., Ricaurte G. A., Chen C., Neumeyer J. L. and Wagner Jr. H. N. (1992) C-11 WIN 35,428 imaging of the dopamine transporter site in living human brain. J. Nucl. Med. 33, 964.